Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
José M de la Torre Hernández
Added:
1 year ago
CRT 23 - In this short interview, we are joined by Dr Jose De La Torre Hernandez (Hospital Universitario Marques de Valdecilla, ES) to provide an update on the OPTIMAL Randomized Controlled Trial, sponsored by the European Cardiovascular Institute. In this ongoing study, 800 patients will be randomized to receive either intravascular ultrasound-guided percutaneous coronary intervention (PCI) or…
View more
Author(s):
Bon-Kwon Koo
Added:
1 year ago
In this short interview from our coverage of ACC.22 late-breaking trials, Dr Bon Kwon Koo (Seoul National University Hospital, KR) discusses the FLAVOUR trial (NCT02673424).
FLAVOUR was a multicentre, non-inferiority, randomised clinical trial which sought to compare the safety and efficacy of FFR-guided stenting and IVUS-guided stenting. Presented first at ACC.22, the trial demonstrated that…
View more
Author(s):
Oluseun Alli
,
David Holmes Jr
Added:
3 years ago
Abstract
Patients with complex and multivessel disease present challenging clinical problems in defining treatment strategies. The Synergy between PCI with taxus and cardiac surgery (SYNTAX) trial, which included both a randomised as well as a registry experience has clarified many issues. These include the extent and severity of the disease, the clinical presentation, and the metrics used for…
View more
Author(s):
Alfonso Ielasi
,
Alaide Chieffo
Added:
3 years ago
A critical stenosis in left main coronary artery (LMCA) is observed in 3–5% of all patients who undergo coronary angiography and in 10–30% of patients who undergo coronary artery bypass grafting (CABG).1 Significant LMCA disease is a high-risk condition because of the extent of jeopardised myocardium.
Current practice guidelines recommend CABG as the standard therapy for patients with…
View more
CRT 23 Late-Breaking Science Video Collection
Video Series
Author(s):
Gautam Kumar
Added:
5 years ago
Dr Gautam Kumar (Emroy Clinic, Atlana, US) discusses the Real World Validation of the Resting Full-Cycle Ratio (RFR): A Novel Non-Hyperemic Index of Coronary Artery Stenosis Severity.
Filmed on-site at CRT 2019 by Radcliffe Cardiology
Questions:
1. What is RFR and how does it compliment/compare to other physiologic indices?
2. What data are you presenting at CRT 2019?
3. What conclusions can…
View more
Author(s):
Mirvat Alasnag
,
Lina Yaqoub
,
Ammar Saati
,
et al
Added:
3 years ago
Historical Perspective and Early Experience
Historically, coronary artery bypass grafting (CABG) surgery has been the gold standard treatment for left main coronary artery (LMCA) disease. However, with the developments and advancements in the interventional cardiology field, percutaneous coronary intervention (PCI) has become a safe alternative management option to CABG in select patients. Today…
View more
Author(s):
Rajiv Rampat
,
David Hildick-Smith
Added:
3 years ago
Left main stem (LMS) disease is identified in up to 5 % of diagnostic angiography cases.1 It has major prognostic significance due to the proportion of myocardium at risk. Many years ago, the Coronary Artery Surgery Study (CASS) registry demonstrated the superiority of coronary artery bypass grafting (CABG) over medical therapy with a 5-year mortality reduction from 43 % to 16 % in symptomatic…
View more
Author(s):
Mirvat Alasnag
Added:
1 year ago
In this short and practice focused review, Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SA) highlights some of the late-breaking clinical trials presented atACC.22from an interventionalist perspective.
Trials covered in detail include:
00:58: SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure
01:46: GHATI: Improving STEMI Management Internationally: Two…
View more